{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
INN:linvekinogene treniplasmid [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04469270: Phase 3 Interventional Completed Diabetic Neuropathy, Painful
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:apazunersen [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
USAN:RUGONERSEN SODIUM [USAN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:frenlosirsen [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04251117: Phase 1/Phase 2 Interventional Active, not recruiting HCC
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
USAN:MAVEROPEPIMUT-S COMPONENT DIDC OLIGONUCLEOTIDE [USAN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:opemalirsen [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04470427: Phase 3 Interventional Completed SARS-CoV-2
(2020)
Source URL:
Class:
NUCLEIC ACID